Strategic enhancement of immune checkpoint inhibition in refractory Colorectal Cancer: Trends and future prospective-Reference-Cited by-同舟云学术

Strategic enhancement of immune checkpoint inhibition in refractory Colorectal Cancer: Trends and future prospective

Published:2021-10 Issue: Volume:99 Page:108017
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Liu Ning^ORCID,Shan Fengping,Ma Mingxing

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference168 articles.

1. Colorectal cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA: a cancer journal for clinicians,2018

3. Global trends in colorectal cancer mortality: projections to the year 2035;Araghi;Int J Cancer,2019

4. Global patterns and trends in colorectal cancer incidence and mortality;Arnold;Gut,2017

5. Ramdzan AR, Abd Rahim MA, Zaki AM, Zaidun Z, Nawi AM. 2019. Diagnostic accuracy of FOBT and colorectal cancer genetic testing: a systematic review & meta-analysis. Annals of global health 85.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic modification in radiotherapy and immunotherapy for cancers;Tzu Chi Medical Journal;2024-09-05

2. Combining immunotherapy and radiation therapy in gastrointestinal cancers: A review;Critical Reviews in Oncology/Hematology;2024-07

3. Objective response after immune checkpoint inhibitors in a chemotherapy-refractory pMMR/MSS metastatic rectal cancer patient primed with experimental AlloStim® immunotherapy;Translational Medicine Communications;2024-05-14

4. Understanding the role of DNA methylation in colorectal cancer: Mechanisms, detection, and clinical significance;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-05

5. Objective Response after Immune Checkpoint Inhibitors in a Chemotherapy-Refractory pMMR/MSS Metastatic Rectal Cancer Patient Primed with Experimental AlloStim® Immunotherapy.;2024-04-03